Conference Summaries

Welcome to the Highlights from AAD 2019

Prof. Nellie Konnikov, MD, FAAD

We are pleased to present highlights from the 2019 Annual Meeting of the American Academy of Dermatology (AAD). Our meeting was held from March 1 to March 5, 2019 in Washington, DC. The AAD conference … [ Read all ]

Clinical Trials

ALOPECIA AREATA

Oral Janus kinase inhibitors PF-06700841 and PF-06651600 provide clinically evident therapeutic effect at 4 and 6 weeks in patients with alopecia areata and greater efficacy over 24 weeks in patients with a shorter duration of their current alopecia episode: Results of a randomized phase 2a trial

Presented by: Elena Peeva, MD, MSc, FACR

ACTINIC KERATOSIS

KX2-391 Ointment 1%, a Novel Dual Sarcome/Tubulin Inhibitor, is Efficacious and Safe in the Treatment of Adults with Actinic Keratosis in Two Phase III Studies

Presented by: Edward Lain, MD, FAAD

ACNE VULGARIS

Clascoterone Topical Cream, 1%: A Novel, Topical, Local, Selective Androgen Receptor Antagonist: Results from Two Phase 3 Studies Treating Children and Adult Patients with Facial Acne Vulgaris

Presented by: Adelaide A. Hebert, MD, FAAD

NEW EMERGING THERAPIES

PSORIASIS

New and Emerging Therapies for Psoriasis

Presented by: Leon H. Kircik, MD, FAAD

AESTHETIC DERMATOLOGY

The Science of Botulinum Toxin Type A: Innovations in Beauty, Health, and Well-being

Presented by: Mark S. Nestor, MD, PhD, FAAD

ACNE AND ROSACEA

New and Emerging Therapies for Acne and Rosacea

Presented by: Diane S. Berson, MD, FAAD

HAIR LOSS

Meeting the Needs of the Hair Challenged Patient

Presented by: Glynis Ablon, MD, FAAD

ATOPIC DERMATITIS

New and Emerging Therapies for Atopic Dermatitis

Presented by: David E. Cohen, MD, MPH, FAAD

NMSC

New and Emerging Therapies for Non-melanoma Skin Cancer – Superficial Radiation Therapy

Presented by: David Goldberg, MD, JD, FAAD

SCARS

Update on Control of Excessive Scarring and Keloids

Presented by: Brian Berman, MD, PhD, FAAD

SKIN INFECTIONS

New and Emerging Therapies in Infections of the Skin

Presented by: Theodore Rosen, MD, FAAD

SYMPOSIA

JAK INHIBITORS

JAK Symposium: Vitiligo

Presented by: John Harris, MD, PhD, FAAD

CUTANEOUS ONCOLOGY

What's New in Cutaneous Oncology

Presented by: Darrell S. Rigel, MD, MS, FAAD

FORUM

PSORIATIC ARTHRITIS

How Psoriatic Arthritis Affects Choice of Biologics

Presented by: Kristina Callis-Duffin, MD, MS, FAAD

ATOPIC DERMATITIS

Atopic Dermatitis: Systemic Treatment

Presented by: Eric Lawrence Simpson, MD, FAAD